Foster James C
FOSTER JAMES C, DIR, reported a transaction classified as exercise at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. involving 21132.000000 shares for an estimated $0.00. Reported holdings after the transaction were 7044.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- Aug 25, 2026
- Filing date
- Aug 27, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
CRL price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001100682-26-000140 Stock Options (Right to Buy)
- Transaction date
- Aug 25, 2026 Filed Aug 27, 2026, 08:21 PM · 2d delay
- Shares
- 21,132 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 7,044 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-16 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 6, 2026.
0 other transactions
0 recent txs